A number of neuroimaging approaches have been applied in classification of AD and MCI, including positron emission tomography (PET) of Aβ-amyloid and tau deposition, structural MRI to detect brain atrophy, diffusion MRI and functional MRI29,57–61. The gene discussed is MAPT; the disease is Alzheimer disease.